Shaw's Eco-Logic

This HND piece looks at the recently filed wrongful death lawsuit against Alkermes, the manufacturer of Vivitrol. We reference an earlier article in which we discussed the problems that drug is having with the FDA—regarding false or misleading advertising. The basic deficiency with Vivitrol is that it shuts off receptors for opioids and endorphins, thus increasing the risk of an overdose.

That's why the drug was much more favored by the criminal justice system than the medical community. That and the fact that unlike methadone and buprenorphine it does not have the possibility of being addictive. Alas, Vivitrol was apparently forced on a hapless patient in California, and he died of an overdose. Expect more such lawsuits to follow.

Read the complete article.